379086375
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
most specific type: Academic Article
language: Inglese
type: Article
type: Generically Dependent Continuant
type: Document
type: Continuant
related by: 379086375
type: Academic Article
type: Entity
type: Information Content Entity
type: Thing

Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T07:21:40
publisher: Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
type: Document
label: RDF description of Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer - http://irises.unisr.it/resource/item/232314

Generically Dependent Continuant
type: Class

Article
type: Class

Inglese
type: Language

Information Content Entity
type: Class